Reversed-phase HPLC analysis of levetiracetam in tablets using monolithic and conventional c18 silica column

Journal of AOAC International

Volumn 93, Issue 4, 2010, Pages 1077-1085

  Can, Nafiz O ^a   Arli, Goksel ^a  

^a ANADOLU UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ANALYTICAL PROCEDURE; CHROMOLITH PERFORMANCE; CONVENTIONAL COLUMNS; DIODE ARRAY DETECTORS; INTERNATIONAL CONFERENCE ON HARMONIZATIONS; PHARMACEUTICAL TABLETS; REVERSED PHASE HPLC; TABLET FORMULATIONS;

SILICA;

ANTICONVULSIVE AGENT; ETIRACETAM; PIRACETAM; SILICON DIOXIDE; TABLET;

ANALOGS AND DERIVATIVES; CHEMISTRY; DEVICES; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF DETECTION; PROCEDURES; QUALITY CONTROL; TABLET;

ANTICONVULSANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; LIMIT OF DETECTION; PIRACETAM; QUALITY CONTROL; SILICON DIOXIDE; TABLETS;

EID: 77956154787     PISSN: 10603271     EISSN: None     Source Type: Journal    
DOI: 10.1093/jaoac/93.4.1077     Document Type: Article

References (39)

1. Patsalos, P.N. (2002) in Antiepileptic Drugs, R.H. Levy, R.H. Mattson, B.S. Meldrum, & E. Perucca (Eds), Lippincott Williams & Wilkins, Philadelphia, PA, p. 428
2. U.S. Food and Drug Administration (1999) Drug Approval Package Keppra (Levetiracetam) Tablets NDA 21035, http://www.accessdata.fda.gov/drugsatfda- docs/nda/99/21035-Keppra.cfm
3. U.S. Food and Drug Administration (1999) NDA 21-35 KEPPRA (Levetiracetam) Tablets Label, http://www.accessdata.fda.gov/drugsatfda-docs/label/1999/ 21035lbl.pdf
4. Ratnaraj, N., Doheny, H.C., & Patsalos, P.N. (1996) Ther. Drug Monit. 18, 154-157
5. Bastlund, J.F., Berry, D., & Watson, W.P. (2005) Neuropharmacology 48, 975-983
6. Dudra-Jastrzebska, M., Andres-Mach, M.M., Sielski, M., Ratnaraj, N., Patsalos, P.N., Czuczwar, S.J., & Luszczki, J.J. (2009) Eur. J. Pharmacol. 605, 87-94
7. Contin, M., Mohamed, S., Albani, F., Riva, R., & Baruzzi, A. (2008) J. Chromatogr. B 873, 129-132
8. Vermeij, T.A., & Edelbroek, P.M. (1994) J. Chromatogr. B 662, 134-139
9. Martens-Lobenhoffer, J., & Bode-Böger, S.M. (2005) J. Chromatogr. B 819, 197-200
10. Juenke, J., Brown, P.I., Urry, F.M., & McMillin, G.A. (2006) J. Anal. Toxicol. 30, 27-30
11. Coupez, R., Straetemans, R., Sehgal, G., Stockis, A., & Lu, Z.S. (2003) J. Clin. Pharmacol. 43, 1370-1376
12. Grim, S.A., Ryan, M., Miles, M.V., Tang, P.H., Strawsburg, R.H., deGrauw, T.J., Fakhoury, T.A., & Baumann, R.J. (2003) Ther. Drug Monit. 25, 61-66
13. Rao, B.M., Ravi, R., Shyam Sundar Reddy, B., Sivakumar, S., Gopi Chand, I., Praveen Kumar, K., Acharyulu, P.V., Om Reddy, G., & Srinivasu, M.K. (2004) J. Pharm. Biomed. Anal. 35, 1017-1026
14. Lancelin, F., Franchon, E., Kraoul, L., Garciau, I., Brovedani, S., Tabaouti, K., Landré, E., Chassoux, F., Paubel, P., & Piketty, M.L. (2007) Ther. Drug. Monit. 29, 576-583
15. Saravanan, G., Jyothi, G., Suresh, Y., Annerao, A., Ramakrishna, M., Yogeshwar Reddy, M., & Ravibabu, B. (2008) Chromatographia 67, 173-177
16. Pucci, V., Bugamelli, F., Mandrioli, R., Ferranti, A., Kenndler, E., & Raggi, M.A. (2004) Biomed. Chromatogr. 18, 37-44
17. Matar, K.M. (2008) J. Pharm. Biomed. Anal. 48, 822-828
18. Guo, T., Oswald, L.M., Mendu, D.R., & Soldin, S.J. (2007) Clin. Chim. Acta 375, 115-118
19. Jain, D.S., Subbaiah, G., Sanyal, M., Pal, U., & Shrivastav, P.S. (2006) Rapid Commun. Mass Spectrom. 20, 2539-2547
20. Gibbs, J.E., Walker, M.C., & Cock, H.R. (2006) Epilepsia 47, 469-478
21. Isoherranen, N., Yagen, B., Soback, S., Roeder, M., Schurig, V., & Bialer, M. (2001) Epilepsia 42, 825-830
22. Isoherranen, N., Roeder, M., Soback, S., Yagen, B., Schurig, V., & Bialer, M. (2000) J. Chromatogr. B 745, 325-332
23. Fay, M.A., Sheth, R.D., & Gidal, B.E. (2005) Clin. Ther. 27, 594-598
24. Greiner-Sosanko, E., Giannoutsos, S., Lower, D.R., Virji, M.A., & Krasowski, M.D. (2007) J. Chromatogr. Sci. 45, 616-622
25. Ramael, S., De Smedt, F., Toublanc, N., Otoul, C., Boulanger, P., Riethuisen, J.M., & Stockis, A. (2006) Clin. Ther. 28, 734-744
26. Coupez, R., Nicolas, J.M., & Browne, T.R. (2003) Epilepsia 44, 171-178
27. Ramael, S., Daoust, A., Otoul, C., Toublanc, N., Troenaru, M., Lu, Z.S., & Stockis, A. (2006) Epilepsia 47, 1128-1135
28. Ivanova, M., Piunti, A., Marziali, E., Komarova, N., Raggi, M.A., & Kenndler, E. (2003) Electrophoresis 24, 992-998
29. Shihabi, Z.K., Oles, K., & Hinsdale, M. (2003) J. Chromatogr. A 1004, 9-12
30. Guiochon, G. (2007) J. Chromatogr. A 1168, 101-168
31. Xu, R.N., Fan, L., Rieser, M.J., & El-Shourbagy, T.A. (2007) J. Pharm. Biomed. Anal. 44, 342-355
32. Ikegami, T., & Tanaka, N. (2004) Curr. Opin. Chem. Biol. 8, 527-533
33. Aboul-Enein, H.Y., & Ali, I. (2005) Talanta 65, 276-280
34. Aboul-Enein, H.Y., & Hefnawy, M.M. (2005) Talanta 65, 67-73
35. Wu, J.T., Zeng, H., Deng, Y., & Unger, S.E. (2001) Rapid Commun. Mass Spectrom. 15, 1113-1119
36. Gerber, F., Krummen, M., Potgeter, H., Roth, A., Siffrin, C., & Spoendlin, C. (2004) J. Chromatogr. A 1036, 127-133
37. International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use (1996) Guideline on Validation of Analytical Procedure-Methodology Q2 (R1), ICH, Geneva, Switzerland
38. U.S. Pharmacopeia (2004) 27th Ed., U.S. Pharmacopeial Convention, Rockville, MD
39. Official Methods of Analysis (2003) 17th Ed., AOAC INTERNATIONAL, Gaithersburg, MD